Pharmaco-economic analysis of direct medical costs of metastatic colorectal cancer therapy with XELOX or modified FOLFOX-6 regimens: Implications for health-care utilization in Australia

2012 ◽  
Vol 9 (3) ◽  
pp. 239-248 ◽  
Author(s):  
Giao Tran ◽  
Stephen P Hack ◽  
Annette Kerr ◽  
Leanne Stokes ◽  
Peter Gibbs ◽  
...  
2016 ◽  
Vol 8 (4) ◽  
pp. 355-358 ◽  
Author(s):  
Thomas L. Sanders ◽  
Hilal Maradit Kremers ◽  
Andrew J. Bryan ◽  
Jeanine E. Ransom ◽  
Bernard F. Morrey

2015 ◽  
Vol 66 (14) ◽  
pp. 1566-1574 ◽  
Author(s):  
Sue Duval ◽  
Kirsten Hall Long ◽  
Samit S. Roy ◽  
Niki C. Oldenburg ◽  
Kelsey Harr ◽  
...  

Author(s):  
Timothy S. Wells ◽  
Lizi Wu ◽  
Gandhi R. Bhattarai ◽  
Lorraine D. Nickels ◽  
Steven R. Rush ◽  
...  

Hearing loss is common among older adults. Thus, it was of interest to explore differences in health care utilization and costs associated with hearing loss and hearing aid use. Hearing loss and hearing aid use were assessed through self-reports and included 5 categories: no hearing loss, aided mild, unaided mild, aided severe, and unaided severe hearing loss. Health care utilization and costs were obtained from medical claims. Those with aided mild or severe hearing loss were significantly more likely to have an emergency department visit. Conversely, those with aided severe hearing loss were about 15% less likely to be hospitalized. Individuals with unaided severe hearing loss had the highest annual medical costs ($14349) compared with those with no hearing loss ($12118, P < .001). In this study, those with unaided severe hearing loss had the highest medical costs. Further studies should attempt to better understand the relationship between hearing loss, hearing aid use, and medical costs.


2010 ◽  
Vol 102 (8) ◽  
pp. 538-546 ◽  
Author(s):  
A. O. Laiyemo ◽  
C. Doubeni ◽  
P. F. Pinsky ◽  
V. P. Doria-Rose ◽  
R. Bresalier ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document